NeoNotes
Journal Club
Andrew B. Kairalla MD, Editor
7-034 | Additional Comments | Previous
Article | Next Article | Search
| List of Articles | Submit
Comments | Index | FSN Home Page | Subscribe
Now
Caffeine Discontinuation Survey
Editor’s Note: We have noticed a wide
variety of practices, and little supportive data, for how long to observe
premature infants in hospital after discontinuation of caffeine for apnea of
prematurity. On August 18, 2006
we prepared a survey on this topic and sent it out to the NeoNotes
subscribers, the NICU-net listserv, and the Vermont-Oxford NICQ listserv.
Within 1 week, we received 263 responses
to this survey. More than 70% of the respondents were neonatologists or NICU
Medical Directors. In this edition of NeoNotes, we will examine the results
of this survey, and review some literature on this topic. The results provide
valuable information for all of us. There were many (94) survey respondents
who added additional
comments about their management of premature infants on caffeine, and some
gave references to support their practice. Click
HERE to review all of
the comments submitted.
I wish to extend a special note of thanks to
those of you who took the time to participate in this survey. ABK.
Survey Results
Clinical Scenario: For each of these questions, assume that we are discussing the management of a 35+ week PMA baby who has been apnea-free on caffeine for 7 days. The baby is clinically stable and otherwise ready for discharge. The parents do not wish to take the baby home on an apnea monitor.
|
1. How often would you discharge this type of infant on caffeine and without home monitoring? |
||
|
|
Response Percent |
Response Total |
|
Almost Always |
10.5% |
27 |
|
Frequently |
5.2% |
13 |
|
Sometimes |
6.2% |
16 |
|
Rarely |
8.1% |
21 |
|
Almost Never |
70.2% |
181 |
|
Total Respondents: |
258 |
|
|
Skipped this question: |
5 |
|
Comment: I was somewhat surprised to see that 16% of
respondents would routinely send premature infants home on caffeine and
without home monitors. As one respondent commented, “There is little evidence
that apnea monitors save lives." ABK.
|
2. You have decided to discontinue caffeine prior to discharge. Do you routinely measure caffeine levels and document a sub-therapeutic level prior to discharge? If NO, go to question 5. |
||
|
|
Response Percent |
Response Total |
|
Yes |
12% |
29 |
|
No |
87.2% |
211 |
|
Total Respondents: |
240 |
|
|
Skipped this question: |
23 |
|
Comment:
Very few respondents (only 12%) rely on
caffeine levels to document a sub-therapeutic level prior to discharge. One
respondent commented that "given wide therapeutic
index we have found monitoring levels to be of little use." Another said:
“there is no level-effect relationship with caffeine”. ABK
|
3. What caffeine level do you consider sub-therapeutic? |
||
|
mcg/mL |
Response Percent |
Response Total |
|
< 10 |
20.5% |
16 |
|
< 5 |
41% |
32 |
|
< 2 |
9% |
7 |
|
Zero |
2.6% |
2 |
|
Other |
26.9% |
21 |
|
Total Respondents: |
78 |
|
|
Skipped this question: |
185 |
|
Comment: There was a wide variety of opinion about what constituted a sub-therapeutic level Several respondents commented that the half life of caffeine in premature infants could be up to 130 hours (5 days or so), so it may take a very long time to clear the drug from the baby. ABK.
|
4. After obtaining a subtherapeutic caffeine level, what apnea-free observation period do you require before hospital discharge without a home monitor. |
||
|
Days |
Response Percent |
Response Total |
|
0 – 3 |
12.2% |
10 |
|
3 – 5 |
15.9% |
13 |
|
5 – 7 |
46.3% |
38 |
|
7 – 10 |
11% |
9 |
|
> 10 |
0 |
0 |
|
Other |
14.6% |
12 |
|
Total Respondents: |
82 |
|
|
Skipped this question: |
181 |
|
|
5. Answer if you do NOT check caffeine levels: After discontinuing caffeine, what apnea-free observation period do you require before hospital discharge without a home monitor. |
||
|
Days |
Response Percent |
Response Total |
|
0 – 3 |
4.6% |
11 |
|
3 – 5 |
10% |
24 |
|
5 – 7 |
54.8% |
131 |
|
7 – 10 |
24.3% |
58 |
|
> 10 |
6.3% |
15 |
|
Total Respondents: |
239 |
|
|
Skipped this question: |
24 |
|
Comments:
The most common apnea-free observation period off of caffeine
was 5-7 days. 87% of respondents indicated that they would start the clock at
the time the drug was discontinued. The remainder would start the observation
period after documenting a sub-therapeutic level. See the
Next Article (Zupancic et al, 7-035) to examine the
cost effectiveness of these "apnea watches". ABK
Click Here to review 94 additional comments submitted during survey completion.
Date: 29 Aug 2006
Time: 09:27:55
The comment quoted at the end of question #1, 'That apnea monitors have not been
shown to save lives' is true only as it applies to reducing the incidence of
SIDS. It does not apply to the use of apnea monitors for "Apnea of Prematurity"
upto 44 weeks gestation. In this setting, and especially when apnea may be
enhanced by a viral illness, apnea monitors may very well save lives.
UserName: Harold Perl MD
Institution: Hackensack University Medical Center/ SIDS Center of New
Jersey
telephone: 201-996-5362
email: hperl@humed.com
Date: 10 Sep 2006
Time: 17:33:59
We typically stop caffeine, resume pulse oximetry if off, & wait a total of 10 days, with a requirement for no events needing intervention for the last 5 to 7 days of that 10 day period. If events occur that are concerning (bradycardia or severe desaturations)we will do a sleep study to assess safety. We have had several infants "crash" about 7 to 10 days after stopping caffeine with severe apnea & desaturations. The resumption of pulse oximetry allows us to pick up the infant who is repetitively desaturating & then further evaluate the infant.
UserName: Lee Harker, MD
Institution: Rogue Valley Medical Center, Medford, OR
telephone: 541-789-4233
email:
lharker@asante.org
Andrew B.
Kairalla MD
Medical Director, Neonatology
Baptist Children's Hospital
8900 N. Kendall Drive
Miami FL 33176
786-596-6669
AndrewK@baptisthealth.net
You may add your own comments to the discussion of this topic by selecting : Submit Comments.